BRAF and Langerhans cell histiocytosis: Thus, LCH pathogenesis requires both limited proliferation of precursor LCH cells harboring the BRAF V600E mutation and the accumulation of gene mutations or an inflammatory trigger that activates the RAS/RAF/mitogen-activated protein kinase kinase (MEK)/ERK signaling pathway [101].